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Summary. Oxidative stress, inflammation and the
aggregation of oxidized, misfolded or aberrant proteins
in the brain induces deregulations in programmed cell
death: apoptosis and autophagy. Apoptosis is one of
processes implicated in aging and neurodegenerative
pathologies, and for the last decade, has been one of the
most studied processes due to its essential role, not only
in aging, but also in many neurodegenerative diseases,
including Parkinson’s, Alzheimer’s and Huntington’s.
However, autophagy being the major intracellular
pathway for the degradation and recycling of long-live
proteins and organelles is widely involved in the
pathogenesis or prevention of many age-related diseases,
including neurodegenerative conditions. Recently,
autophagy activation has been considered as part of the
cellular responses to elevated oxidative stress,
eliminating unwanted, damaged and oxidative structures;
thus favouring, in this way, the key anti-aging
mechanism associated with the caloric restriction.
Longevity factors, such as sirtuins, and redox-sensitive
transcriptional factors, such as NF-κB and p53, can also
regulate basal autophagy in cells, with a direct impact on
longevity and the development of inflammation and
neurodegeneration. Here, we reviewed the critical
changes of autophagy in the aging and neuro-
degenerative brain and the role of key regulators of
autophagy, which are directly related to oxidative stress,
inflammation and longevity pathways. 
Key-words: Neurodegeneration, Autophagy, Sirtuins,
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Introduction to oxidative stress and inflammation in
the aging brain
Aging is defined as a complex, irreversible and
multifactorial process that leads to changes over time,
affecting multiple biological functions, with a gradual
deterioration in the adaptability of the organisms to
environmental changes and stressful conditions. These
changes are detected at all levels, molecular, cellular,
tissular levels and organismal (Yu and Chung, 2006),
leading to functional systemic disorders related to the
aging process and a higher risk of succumbing to age-
related pathologies, such as neurodegenerative disease,
diabetes, autoimmune and inflammatory diseases and
cancer. Initially, aging was proposed as the major risk
factor in most neurodegenerative disorders (Floyd and
Hensley, 2002). The incidence of neurodegenerative
diseases, such as Alzheimer’s disease (AD) and
Parkinson’s disease (PD) increases significantly with age
(Wilson et al., 2007). Given that the ratio of elderly
people is increasing, it is crucial that research uncovers
the mechanisms associated with senescence and
implicated in the transition from benign aging to
degenerative disease to prevent the development of the
age-related pathologies and in particular, the cognitive
decline associated with aging. In the central nervous
system, the neuroendocrine changes observed during
aging appear to be more related to disorders of the
relationship between neural and hormonal signals, rather
than alterations of specific structures (Ferrari and Magri,
2008; Ferrari et al., 2008).
However, in a review of aging, it is essential discuss
the previously well-known processes underlying the
aging phenomenon, such as oxidative stress and its
subsequent inflammation. Oxidative stress is the main
causal factor of aging and the development of various
diseases, including age-related sporadic degenerative
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diseases (e.g., AD, atherosclerosis and diabetes)
(Dubinina and Pustygina, 2007). In fact, the
enhancement of oxidative stress resistance is considered
to be the mechanism underlying the extended longevity
of genetic variants of non-mammalian and mammalian
organisms (Agarwal and Sohal, 1996; Holzenberger et
al., 2003; Madsen et al., 2004; Ayyadevara et al., 2005,
2008). The free radical theory of aging proposes a slow
and progressive generation of reactive oxygen species
(ROS), an unavoidable consequence of life in an aerobic
environment, resulting in the accumulation of defective
cellular components (Harman, 1956, 1992). Oxidative
stress can be defined within the context of a subtle
changed redox status (Yoon et al., 2002). In this regard,
the age-related oxidative stress in mammalian cells is
generated by a redox deregulation (Humphries et al.,
2006) as a consequence of prominent enzymatic defects,
leading to an increased production of free radicals,
including ROS, reactive nitrogen species (RNS) and
other oxidant agents, together with an important
decrease in antioxidant levels and impairment of the
repair of oxidative damages. Hence, aging occurs as the
result of accumulative and unrepaired damage in the
cellular constituents, best exemplified by products of
lipid peroxidation, protein oxidation and toxic
aggregates, such as lipofuscin, toxic proteins (α-
synuclein, phosphorylated Tau), the glycoxidation of
macromolecules and oxidative modifications in nuclear
and mitochondrial DNA (Stadtman, 1992; Beckman and
Ames, 1998; Sohal, 2002) (Fig. 1). Oxidatively altered
structures and functions are detected and accumulated at
all levels along the aging phenomenon (Yu and Chung,
2006). An increase in protein carbonyl levels has been
demonstrated for various brain regions including the
hippocampus (Siqueira et al., 2005), a key area of brain
implicated in learning and memory functions. The
effects of aging on energy production or changes in ROS
production could be particularly detrimental in non-
proliferating neuronal tissues. In fact, damage by ROS is
more exacerbated in the brain, because it is highly
vulnerable to free radical damage due to its higher
oxygen utilization, high concentrations of
polyunsaturated fatty acids and transition metals, such as
iron, and low concentration of cytosolic antioxidants
(Reiter, 1995).
Inflammation is another important factor that affects
the normal brain and, in particular, the aging of the
brain. The age-related chronic inflammatory state creates
an activated immune response that includes the acute
phase protein response, cytokines (interferon and
interleukins), macrophages, lymphocytes, and other
immune system cells. Nitric oxide (NO) and nitrite
levels (NO•) accurately reflect the nitrosative stress
status that is caused by inflammation. The increase of
nitrite levels is particularly relevant because it is well
documented that NO• and its toxic metabolite,
peroxynitrite, can inhibit components of the
mitochondrial respiratory chain, leading to a cellular
energy deficiency and, eventually, to cell death (Cassina
et al., 2000; Brown, 2001). Within the brain, neurons, in
contrast to astrocytes, appear particularly vulnerable to
the effects of nitrosative stress. Mammalian
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Fig 1. Oxidative damages associated with
aging and neurodegeneration. The increase of
reactive oxygen species (ROS) during aging in
the brain leads to signif icant damage to
molecules that are key for cell survival. The
oxidative modifications of l ipids (l ipid
peroxidation) from the cellular membrane lead
to changes in cell membrane fluidity and can
also favor oxidative modifications of proteins,
leading to the formation of toxic protein
aggregates inside cells and the alteration of
several enzymatic activities. The oxidative
modifications of nuclear DNA can favor
mutations. Other important oxidative alterations
that can compromise cell survival include
alterations of the cytoskeleton, by the oxidation
of structural and microtubule-associated
proteins that stabil ize the cytoskeleton.
Transcription factors can be activated under
oxidative stress, such as p53 and NF-κB, the
latter promotes the expression of several pro-
inflammatory genes. In addition, the alteration
of several organelles, such as mitochondria,
results in the generation of less cellular ATP
and the production of even more ROS, further
contributing to oxidative damage. The
dysfunction of the endoplasmic reticulum (ER)
alters calcium homeostasis and multiple calcium-dependent signaling pathways. The oxidative modifications of lysosomal membranes release
proteolytic enzymes (such as cathepsins) to the cytosol, which can be pro-apoptotic signals.
inflammation in the aging brain is also associated with
the activation of the NF-κB transcription factor system
(Caballero et al., 2008) and the chronic activation of NF-
κB signaling has the capacity to induce the senescent
phenotype associated with aging (Salminen and
Kaarniranta, 2009a). The NF-κB system is an ancient
host defense system concerned with immune responses
and different external and internal dangers, such as
oxidative and genotoxic stress. In addition to being the
master regulator of inflammatory responses, NF-κB
signaling can also regulate several homeostatic
responses through its anti-apoptotic effects (Michiels et
al., 2002) and antioxidant functions; NF-κB can increase
the expression of antioxidant enzymes in responses to
elevated oxidative stress (Tomas-Zapico and Coto-
Montes, 2005). Therefore, an increased rate of free
radical generation, inflammation and the inefficiency of
the reparative/recycling mechanisms are factors that
primarily contribute to the age-related deterioration
during the aging brain, what implies that an antioxidant
treatment can be highly beneficial against these
processes (Gutierrez-Cuesta et al., 2007; Caballero et al.,
2008, 2009; Garcia et al., 2010).
Autophagy, oxidative stress and neurodegeneration
In postmitotic cells, such as neurons, which cannot
become senescent because they are already terminally
differentiated, autophagy (self-eating) is a major
homeostatic mechanism to cope with stress. The
damaged organelles, long-lived or aberrant proteins and
superfluous or aged portions of the cytoplasm are
eliminated by the autophagy-lysosomal system that does
not compromise cellular functions and tissue
homeostasis. The best characterized form of autophagy,
macroautophagy (mainly referenced in this review),
involves the rearrangement of sub-cellular membranes to
sequester parts of cytoplasm and organelles in double-
membrane vesicles, called autophagosomes, for delivery
to lysosomes where the sequestered cargo is degraded
and recycled within autophagolysosomes (Cuervo et al.,
2005; Klionsky, 2005; Cuervo, 2008). This sequestration
process is controlled by the mammalian target of
rapamycin (mTOR) kinase pathway, the major negative
regulator of macroautophagy, which is regulated by
insulin via the phosphoinositol 3 kinase/serine-threonine
protein kinase (PI3K/AKT) pathway and by specific
amino acids via AMP kinases (Petiot et al., 2000).
Upstream of mTOR, macroautophagy can be inhibited
by the insulin/IGF-1 (insulin-like growth factor-1)
receptor pathway (Levine and Kroemer, 2008). In
contrast, microautophagy sequesters the cytosolic
materials through direct invagination of the lysosome
membrane in a constitutive mechanism. Lastly,
chaperone-mediated autophagy (CMA) is responsible for
the selective lysosomal degradation of cytosolic proteins
with a particular pentapeptide motif (KERFQ), after
targeting them with a cytosolic chaperone complex and
by their selective translocation after binding to the
lysosome-membrane associated protein type 2a
(Lamp2a) (Cuervo et al., 2005). 
The primary roles of autophagy are the baseline
turnover of intracellular proteins and organelles, the
production of amino acids in nutrient emergency, and the
regression of retired tissues (Bergamini et al., 2007).
But, in recent works, autophagy has started to be
considered as a cytoprotective response during stress
conditions (Cuervo, 2004; Moore, 2008) to remove toxic
or altered components and unwanted or unnecessary
organelles (mitochondrias, peroxisomes, etc...),
recycling the components for reuse (Kim and Klionsky,
2000). These actions are a quality control mechanism for
organelles, particularly important for neuron survival,
since these might, otherwise, can lead to cell death by
apoptosis (Erlich et al., 2006; Li et al., 2006; Cao and
Klionsky, 2007). In this way, ROS induce cytoprotection
since they are essentials to stimulate autophagy by
boosting the activity of autophagic protein 4 (ATG4)
(Scherz-Shouval et al., 2007). During intracellular stress,
including the aggregation of misfolded proteins (Qin et
al., 2003), the accumulation of altered organelles
(Klionsky and Ohsumi, 1999; Klionsky and Emr, 2000)
and during starvation and hypoxia conditions (Yen and
Klionsky, 2008), the degradation by basal autophagy is
increased to allow cell survival. Recently, the different
types of macroautophagy have been characterized by the
stimuli that mediate their activation or by the molecular
mechanisms involved in the activation and execution of
autophagy; basal in-bulk macroautophagy and
starvation-induced autophagy are at the extremes of this
scale, whereas quality-control autophagy and autophagy
induced by protein aggregates, organelle stress or
patho¬gen invasion are located in the middle levels of
this classification (Wong and Cuervo, 2010) along with
the essential properties of the cellular stress responses.
Moreover, in non-physiological situations, autophagic
cell death, known as type II non-apoptotic programmed
cell death, which has been also reported in neurons
(Larsen and Sulzer, 2002), shows a negative feedback on
apoptosis; autophagy can lead to cell death when
apoptosis is inhibited (Shimizu et al., 2004) and
consequently, if autophagy is inhibited under nutrient
starvation conditions, cell death by apoptosis is
accelerated (Maiuri et al., 2007). 
It is well-known that a decline of autophagic
degradation in older tissues (Cuervo and Dice, 1998,
2000) impairs the cellular housekeeping process of
aberrant and dysfunctional molecules, organelles and
protein aggregates. Defective autophagy has been
extensively linked to aging and the development of age-
related neurodegeneration (review in Wong and Cuervo,
2010). At first sight, macroautophagy is altered during
aging as a consequence of impaired autophagosomes
formation or maduration to autophagolysosomes
(Terman, 1995). In the brain of mice prone to accelerated
senescence, control quality by autophagy is severely
altered contributing to the accumulation of toxic protein
aggregates that are already observed at early ages
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(Caballero et al., 2008, 2009). In addition, it is well-
known that defects in autophagic activity and the loss of
the basal autophagy level causes neurodegeneration
(Hara et al., 2006; Komatsu et al., 2006) such as occurs
in AD and Huntington’s diseases (HD) (Levine and
Kroemer, 2008). Reduced autophagy induction,
enhanced in the repression of autophagy, altered cargo
recognition, inefficient autophagosome/lysosome fusion
or inefficient degradation of the autophagic cargo in
lysosomes are all potential defects that could influence
the malfunctioning of macroautophagy in different
neurodegenerative disorders (Wong and Cuervo, 2010).
Indeed, Pickford et al. (2008) reported that cellular
levels of autophagy-related protein beclin1 were often
correlated with autophagic activity, and that the
heterozygous deletion of beclin-1 leads to
neurodegeneration (Pickford et al., 2008). Therefore, the
elimination of basal neuronal autophagy is sufficient to
cause neurodegeneration in the absence of other insults
(Hara et al., 2006; Komatsu et al., 2006). Thus, it seems
that increased autophagic activity might help to clear
aggregates of toxic proteins (such as mutant α-synuclein
and Huntingtin), which are associated with pathologies
such as Parkinson’s and Huntington’s disease (Lee and
Gao, 2008). However, autophagy functions may not
always be beneficial (Hashimoto et al., 2009). For
instance, Yu et al. (2005) demonstrated that induced
neuronal macroautophagy in the presenilin (PS)/Aß
precursor protein (APP)-mouse model of ß-amyloidosis
was impaired causing the profuse accumulation of
autophagic vacuoles (AVs) in dystrophic dendrites due to
an impaired maturation of AVs to lysosomes (Yu et al.,
2005). An extensive basal activation of autophagy, rather
than the characteristic decline occurred during normal
aging, could contribute to the systemic degeneration and
premature aging observed in progeroid mouse models
(Mariño et al., 2008). Therefore, the dual role of
autophagy, in cytoprotection and cell death as well as its
impact on longevity is one of the most fascinating
features of this process, which clearly has a direct impact
on age-related development of neurodegeneration (Table
1). 
Autophagy and longevity: role of key regulators of
cellular stress responses
The accumulation of cellular damage is the major
hallmark of the aged cell; oxidized, misfolded, cross-
linked or aggregated macromolecules and damaged
organelles cannot function properly and can actively
compromise cellular functions. However, the overall rate
at which damage is accumulated is influenced by
conserved longevity pathways and redox-sensitive
transcriptional factors, which have key roles in cell
responses to stress conditions. Autophagy activity is
essential for life-span extension and cytoprotective
responses during cellular stress because it can eliminate
unwanted or damaged intracellular materials; this
activity is, therefore, regulated by longevity proteins and
redox-sensitive factors, thus making autophagy a central
regulatory mechanism for aging (Salminen and
Kaarniranta, 2009b). Thereby, we review the regulatory
features of sirtuins, p53 proteins and the NF-κB system
in autophagy activity with special emphasis on their
impact in the aging brain or under neurodegeneration.
Autophagy and NF-κB activation
The NF-κB/Rel DNA-binding complexes contain
the Rel family components, RelA/p65, c-Rel, and RelB,
as well as the NF-κB components p50 (p105) and p52
(p100). The inhibitory IκB components α, ß, γ, ε and
Bcl-3, the IKK kinases complex proteins IKKα and
IKKß, and the regulatory NEMO protein can trigger NF-
κB activation. The NF-κB complexes are normally
located in the cytoplasm because they are bound to the
inhibitory IκB proteins. Multiple stressors, such as
oxidative stress, DNA damage and death receptor
activation, induces the phosphorylation of the IκB
proteins that are subsequently ubiquitinated and
degraded via the proteasome. After their release from the
IκB proteins, NF-κB complexes can translocate to nuclei
and activate the transcription of a number of specific
target genes, especially those of inflammatory genes that
are up-regulated during aging (Haddad, 2002; Salminen
and Kaarniranta, 2009a). NF-κB signaling is the master
regulator of inflammatory and immune responses (Qing
et al., 2006) and plays a key role in the cellular
responses to oxidative stress (Michiels et al., 2002) by
its antioxidant and anti-apoptotic functions (Tomas-
Zapico and Coto-Montes, 2005). Remarkably, the NF-
κB system is key in aging regulation since a reduced
longevity could be due to the constitutive activation of
NF-κB factor by ROS, which can lead to cancer,
inflammation and others diseases related to aging (Libert
et al., 2006). For this reason, the DNA-binding activity
of the NF-κB complex is significantly increased in
several rat and mouse tissues during aging (Salminen
and Kaarniranta, 2009a). Moreover, NF-κB has been
considered as a new therapeutic target against
inflammatory damages associated with neuro-
degenerative diseases (Camandola and Mattson, 2007).
Inflammation is a potent inhibitor of autophagy
(Salminen and Kaarniranta, 2009b), and remarkably, the
activation of NF-κB system can suppress autophagy
functions, thus contributing to neurodegeneration
(Caballero et al., 2008, 2009). Other studies have also
reported the reciprocal inhibition between autophagy and
NF-κB activation (Djavaheri-Mergny et al., 2007; Zhu et
al., 2011), therefore, NF-κB signaling might be
considered as a potent inhibitor of autophagocytosis
(Lee et al., 2007; Dan and Baldwin, 2008; Salminen and
Kaarniranta, 2009b). Similarly, autophagy negatively
regulates NF-κB through the autophagocytosis-mediated
degradation of the NF-κB-inducing kinase (NIK) and
IKK kinases (Qing et al., 2006, 2007). Notably, IKK can
also promote the autophagic pathway in an NF-κB -
independent manner (Criollo et al., 2010; Comb et al.,
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2011). All these observations suggest that, the
interaction between oxidative stress-induced NF-κB
activation and autophagy activity is important in the
regulation of cellular responses in the aged brain. Aging-
related chronic inflammation by NF-κB activation can
contribute to neurodegeneration by two ways; the
defective/altered autophagy in neurons (Caballero et al.,
2008, 2009) and cell death and inflammatory damages
due to astrocytes activation (Hwang et al., 2010). Thus,
it is reasonable that signaling via longevity factors, such
as FoxOs and sirtuins, can inhibit the NF-κB system and
simultaneously protect against chronic inflammation
duration the aging process (Salminen et al., 2008) to
improve longevity. 
Sirtuins and autophagy 
Lifespan extension seems to depend on the efficient
maintenance of autophagic degradation (Hars et al.,
2007; Jia and Levine, 2007; Cavallini et al., 2008; Vellai
et al., 2009). Therefore, there is an increased interest in
studying the longevity signaling pathways that can
regulate autophagy. Considering that acetylation is an
important post-translational modification, which
regulates autophagosome formation (Lee et al., 2008),
activity of sirtuins becomes more interesting for
understanding the aging process. Sirtuins are NAD+-
dependent histone/protein deacetylases that are
homologous to the yeast protein Sir2 (silent information
regulator 2) (Sinclair et al., 1998). The mammalian
sirtuins (SIRT1-SIRT7) have important functions in the
regulation of metabolism, growth and differentiation,
inflammation, cellular survival and aging (review in
Salminen and Kaarniranta, 2009c). Oxidative stress,
mitochondrial dysfunction, inflammation and defective
autophagy are hallmarks of the aging process, and
therefore, it is reasonable to think that the regulation of
sirtuins in these processes is essential for longevity
control. Moreover, sirtuins play a role in mitochondrial
ROS production (Nakagawa and Guarente, 2011) and
can also mediate peroxisome proliferator-activated
receptor γ coactivator-1 α (PGC-1α) effects to regulate
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Table 1. An insight into the impact of changes in autophagy on neurodegeneration and longevity.
Positive or Negative effects of Autophagy in Neurodegeneration/Longevity References
Life span-extending effect of the p53 orthologue CEP-1 mutation by increasing baseline autophagy in C.elegans Tavernarakis et al. 2008
Promoting levels of autophagy in the nervous system enhances longevity and oxidant resistance 
in adult Drosophila melanogaster. Simonsen et al., 2008
Autophagy is required for lifespan extension in various long-lived mutant organisms Cuervo, 2008; Reviewed in Vellai et al., 2009
Autophagy is required for dietary restriction-mediated life span extension in C.elegans Jia and Levine, 2007
Caloric restriction and resveratrol prolong longevity via the Sirt-1 dependent induction of autophagy Morselli et al., 2010
Impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to
neurodegenerative disorders such as Parkinson's disease Matsuda and Tanaka, 2010
Autophagy may also function to restrict lifespan in C.elegans Hashimoto et al., 2009
Cytoprotective function of autophagy-lysosome pathway by disruption of the synthesis, transport, 
folding or glycosylation of ER-targeted in Drosophila Arsham and Neufeld, 2009
Defective autophagy has been linked to age-related neurodegeneration development
Cao et al., 2006; Komatsu et
al., 2006; Hara et al., 2006;
Pickford et al., 2008
ß-amyloid production by accumulated autophagy vacuoles in dystrophic dendrites of the presenilin 
(PS)/A‚ precursor protein (APP) mice model Yu et al., 2005
Autophagy activity helps to clear aggregated-prone proteins from the cytosol Williams et al., 2006
Autophagy alterations in the brain of senescence accelerated mouse prone 8 (SAMP8) Caballero et al., 2009; Ma et al., 2011
Increased autophagy clearance toxic proteins associated with pathologies such Parkinson’s and Huntington’s disease Ferrucci et al., 2008; Lee and Gao, 2008
Autophagy has anti-aging effects being beneficial toward retardation of aging and prevention of age-related disease in humans Bergamini et al., 2007
Autophagy induction in the systemic metabolic response associated with premature aging Mariño et al., 2008
TOR-mediated autophagy suppresses cell death in Drosophila model of Huntington’s disease Wang et al., 2009a
Loss of PINK1 or Parkin results in failure of mitophagy and may contribute to the pathogenesis of Parkinson’s disease Geisler et al., 2010
Contribution of the autophagy-lysosomal genes deficits to Alzheimer and Parkinson diseases 
and potential involvement in tuberous sclerosis, neuronal ceroid-lipofuscinoses, sepsis and neoplasms Jegga et al., 2011
mitochondrial biogenesis and the supply of new
mitochondrias (Aquilano et al., 2010; Kong et al., 2010).
Remarkably, SIRT1 is induced by calorie restriction
increasing organism longevity in yeast, worms, flies and
mammals (Guarente and Picard, 2005; Vellai et al.,
2009); SIRT1 can be directly associated with the
sirtuins-dependent induction of autophagy (Morselli et
al., 2010) for the clearance of old and damaged
organelles. In this regard, SIRT1 activity can regulate
autophagocytosis by the direct deacetylation of
autophagic proteins, such as ATG5, ATG7 and ATG8,
thus activating the basal level of recycling autophagy
activity (Lee et al., 2008). Likewise, SIRT1 activity can
inhibit NF-κB-mediated transcription by the
deacetylation of the RelA/p65 subunit of the NF-κB
complex, protecting against age-related inflammation
(Salminen et al., 2008) and hence also favoring
autophagy functions. However, it should be noted that
the activation of sirtuins, per se, induces the autophagy
required for the lifespan-prolonging effects of caloric
restriction and pharmacological Sirtuin-1 activators
(Morselli et al., 2010). Sirtuins regulate not only several
physiologic conditions (embryogenesis, glucose
metabolism, apoptosis, autophagy, chromatin integrity,
and transcriptional state) but also pathologic (diabetes,
cancer, cardiovascular disorders, and neurodegeneration)
conditions. Driven by all these considerations, sirtuins
have been considered as novel therapeutic targets to treat
age-associated diseases (Lavu et al., 2008). Under
neurodegenerative conditions, SIRT1 appears to protect
against certain forms of neuronal degeneration (Kim et
al., 2007). In fact, SIRT1 activation by the natural
phytocompound resveratrol, proved beneficial for
reducing amyloid-beta protein accumulation in both in
vitro and in vivo models of AD (Albani et al., 2009).
Resveratrol and caloric restriction also induced
neuroprotective actions by SIRT1 activation in
Parkinson’s disease, Huntington’s disease and epilepsy
(Qin et al., 2006; Albani et al., 2010). In this regard,
several neurodegenerative conditions and other age-
related pathologies can be benefit from the induction of
basal autophagy though an increase of sirtuins activity
(Lee et al., 2008). Remarkably, SIRT1 expression
decreases with age in the senescent and
neurodegenerative brain (Gutierrez-Cuesta et al., 2008),
and autophagy is altered (Caballero et al., 2009; Wong
and Cuervo, 2010). Therefore, the decreased SIRT1
expression in the aging brain might have two important
consequences: to have a negative and direct effect on
autophagy or to indirectly favor age-related
inflammation through NF-κB activation, which also
interferes in autophagy. Sirtuins likely play a key role in
brain susceptibility to neurodegeneration during aging
through its well-established effect on the regulation of
autophagy in physiological and pathological conditions. 
The p53 and autophagy
Considered the “guardian of the genome” and main
tumor suppressor, the p53 transcriptional factor responds
to a wide variety of stress signals, including DNA
damage, hypoxia, heat/cold shock, nutrition starvation
and oncogene activation, to maintain genomic stability
by limiting the error frequency of cell growth and
division. The p53-mediated cellular responses, such as
cell cycle arrest, DNA repair and apoptosis, depend on
cell type, environmental context and degree of stress
(Feng, 2010). The relationship between p53 and aging
appears to be complex. The p53 functions decline with
aging, increasing tumor incidence in older organs (Feng
et al., 2007). Remarkably, there is functional antagonism
between p53 and NF-κB signaling; the aging-associated
decline in p53 efficiency favors the NF-κB-mediated
senescence and inflammation (Salminen and
Kaarniranta, 2011). It is well-known that aberrant or
non-regulated p53 activity could also accelerate aging
(Serrano and Blasco, 2007). Indeed, mice models
showing over-expressing of p53 and increased p53
activity present shortened life-spans (Tyner et al., 2002;
Maier et al., 2004). However, mouse models with
controlled, constitutive p53 activity are resistant to
cancer and display a normal life span and aging (Garcia-
Cao et al., 2002, 2006). In short, inappropriate p53
activity promotes aging, whereas the normal and
robustly regulated p53 response provides protection
from the aging process (Vigneron and Vousden, 2010).
Furthermore, p53 can regulate aging by autophagy
(Tavernarakis et al., 2008). Recently, it has been
suggested a regulation of senescence by p53 due to its
ability to promote or inhibit oxidative stress and
autophagy according its level of acetylation, which will
have contrary effects on longevity and aging (Vigneron
and Vousden, 2010). In this regard, it is important to
note that nuclear p53 can induce autophagy through its
transcriptional effects, while cytoplasmic p53 acts as a
master repressor of autophagy (Tasdemir et al., 2008;
Green and Kroemer, 2009). Thus, loss of cytoplasmic
p53 can induce autophagy in humans, mice and
nematode cells (Tasdemir et al., 2008), and this effect
has been linked to longevity in nematodes (Tavernarakis
et al., 2008). The mechanism through which p53 can
activate autophagy includes the down-regulation of IGF-
1/AKT-1/mTOR pathways and the up-regulation of the
transcription of autophagy proteins, such as the damage-
regulated autophagy modulator (DRAM) and Sestrin2
(Green and Kroemer, 2009; Feng, 2010). However, as
with aging, inappropriate p53 activity can contribute to
neurodegeneration by inducing apoptotic and/or
autophagic cell death (Wang et al., 2008, 2009b; Pehar et
al., 2010). Interestingly, p53 was the first discovered
non-histone target of SIRT1 (Luo et al., 2001). The
deacetylation of p53 by SIRT1 leads to the inactivation
of p53-mediated transcription (Vaziri et al., 2001; Luo et
al., 2001), which is important in neuronal survival
(Hasegawa and Yoshikawa, 2008). In fact, SIRT1 can
regulate both types of known p53-mediated apoptotic
pathways, transcriptional dependent and independent
mechanisms (Yi and Luo, 2010) and, even, block the
nuclear translocation of p53 induced by oxidative stress
via deacetylation (Han et al., 2008). As a potent tumor
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suppressor, SIRT1 can negatively regulate various tumor
suppressors, including p53, ß-catenin and survivin (Yi
and Luo, 2010) and SIRT1 interactions with p53 can also
regulate both autophagic degradation and lifespan
extension (Salminen and Kaarniranta, 2009c). Therefore,
considering these observations, the regulation of p53
responses could favor autophagy and neuronal survival
during the aging brain with an important positive impact
on longevity and against neurodegeneration. 
Autophagy in animal models of accelerated aging
SAMP8 mice are non-genetically modified mice that
show a shortened life-span with important learning and
memory deficits (Miyamoto et al., 1986, 1992;
Miyamoto, 1997), which are also well-known age-
related signs and symptoms of human aging.
Interestingly, for the actual aging research, the SAMP8
mouse appears to be an excellent model for studying the
mechanism of age-related cognitive dysfunction and
neurodegeneration (Alvarez-Garcia et al., 2006;
Caballero et al., 2008, 2009; Zhang et al., 2009),
displaying degenerative changes caused by the
impairment of oxidative metabolism (Zhang et al.,
2009), resembling those observed in brain affected with
AD (Diez-Vives et al., 2009). Indeed, oxidative-stress
related alterations in SAMP8 mice are observed at early
ages not only in the brain, but also in various key organs,
such as the liver and spleen (Alvarez-Garcia et al., 2006;
Lardone et al., 2006; Caballero et al., 2008, 2009). In
addition, increased levels of protein carbonyl and several
neurodegenerative markers, such as phosphorylated Tau
in the neurofibrillary tangles, α synuclein (Alvarez-
Garcia et al., 2006; Caballero et al., 2008) and ß-amyloid
aggregates (Morley, 2002; Gutierrez-Cuesta et al., 2008),
are described in the SAMP8 brain. The toxic protein
aggregates from the aged brain of SAMP8 mice were
also associated with deficits in specific lysosomal and
cytosolic proteolytic activities (Caballero et al., 2009),
although without an important neuronal loss by
apoptosis (Takeuchi et al., 2000). Neurotransmission in
the SAMP8 brain is also altered by a decrease in levels
of NMDA (N-methyl-d-aspartic acid) (Tomobe and
Nomura, 2009), MT-1 (high-affinity G-protein-coupled
melatonin receptor) and ROR-α (Retinoic acid receptor-
related orphan receptor alpha) receptors (Caballero et al.,
2008) together with an early loss in adenosine receptors
(Castillo et al., 2009). Inflammatory processes were
driven by the strong activation of NF-κB in the SAMP8
brain (Caballero et al., 2008; Gutierrez-Cuesta et al.,
2008). It is remarkable that, although our previous
research did not show the activation of autophagy in the
brain of 5 and 10-month-old SAMP8 mice (Caballero et
al., 2009), more recent work have described autophagic
markers in the 7-month-old SAMP8 brain, especially in
the cortex and hippocampus, which decrease at 12-
months of age, displaying autophagic vacuoles
accumulation in the axons and cytoplasm in both areas,
similar to late-onset AD (Ma et al., 2011). Therefore, it
must be emphasized that the age-related autophagy
alterations in the brains of SAMP8 mice can be
associated with their susceptibility to age-related
neurodegeneration and early cognitive decline. 
Thus, taken together, there are several factors that
might impair autophagy in the SAMP8 brain. Higher
oxidative stress-induced NF-κB signaling in the SAMP8
brain (Caballero et al., 2008) would lead to age-related
pro-inflammation (Rodriguez et al., 2007), and both
factors are well-known autophagy suppressors
(Salminen and Kaarniranta, 2009a,b). Notably, p53 was
also increased with age in the SAMP8 brain (Caballero
et al., 2009), but without a higher activation by
acetylation (Gutierrez-Cuesta et al., 2008). Thus, the
alteration of both the p53 and NF-κB responses might be
also a key factor in regulating autophagy levels.
Remarkably, SIRT1 expression decreased with age in the
SAMP8 brain (Gutierrez-Cuesta et al., 2008). Therefore,
the loss of this longevity factor, which plays a key role
in autophagy induction (Lee et al., 2008), together with
an increased inflammatory process and proteolytic
deficiencies, might play a role in autophagy impairments
in SAMP8. Moreover, the SAMP8 brain is also a useful
model for glucose hypometabolism, which is also
observed in the aged brain and with dementias
(Kurokawa et al., 1996; Ohta et al., 1996). A diminished
glucose metabolisms has been shown to induce the
hyperphosphorylation of Tau (Planel et al., 2004) and
increased production of the ß-amyloid peptide (Gabuzda
et al., 1994) and both markers are also observed in the
SAMP8 brain (Gutierrez-Cuesta et al., 2008; Caballero
et al., 2009). More recent studies have revealed that
these mice have low glucose levels in serum as
compared with their control SAMR1 mice (Jiang et al.,
2008). The energy production (ATP) in the central
nervous system is based almost exclusively upon the
oxidation of glucose, and in that way, diminished energy
production in the brain down-stream impairs ATP-
dependent processes, such as synaptic functions,
ubiquitin-proteasome system degradation and, therefore,
also autophagy degradation. Likewise, there is an
increased glucose transport to the brain by increased
GLUT3 expression in zones, such as the cortex, of the
SAMP8 brain (Sato et al., 1994). Glucose, considered a
pro-aging factor, could activate the insulin receptor
signaling pathway (Kassi and Papavassiliou, 2008),
leading to the subsequent activation of the mTOR
complex, which inhibits several steps in autophagosome
formation (Kamada et al., 2000). In this way, the
increased glucose transport to the SAMP8 brain,
together with a decreased glucose metabolism, could
also negatively affect autophagy in these mice. Taken
together, these results suggest that there are several
longevity factors and oxidative/nitrosative stress-related
signaling pathways that can disrupt cellular responses to
increase the susceptibility of the SAMP8 brain to early
neurodegenerative changes.
Finally, the Zmpste24-deficient mouse is a reliable
model of human Hutchinson-Gilford progeria, a type of
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accelerated aging in which autophagy plays an important
role. These progeroid mice, display defects in nuclear
architecture because Zmpste24 (also called FACE-1) is a
metalloproteinase involved in the maturation of laminin
A and is an essential component of the nuclear envelope.
These nuclear envelope abnormalities are associated
with premature aging and progeroids syndromes in both
mice and humans (Mariño et al., 2008). Surprisingly,
these prematurely-aged mouse models exhibit an
extensive basal activation of autophagic degradation
instead of the characteristic decline in this process that
occurs during normal aging. Therefore, the increase in
autophagy in Zmpste24-deficient mice was linked to
severe metabolic alterations in glucose and lipid
metabolism, which lead to elevated liver kinase B1 and
the up-regulation of the AMP-activated protein kinase
pathway, which ends with mTOR inhibition (Mariño et
al., 2008). The authors noted that these metabolic
changes, including lower insulin and glucose levels in
blood, respectively, resemble those occurring under
calorie restriction or in other situations reported to
prolong life-span. In this regard, they have described a
novel and paradoxical role for autophagic cellular
degradative pathways during pathological aging
processes (Mariño et al., 2008; Mariño et al., 2010).
Remarkably, the chronic activation of autophagy can
have a negative effect on cell death (Maiuri et al., 2007).
Hence, the progressive muscle and cardiac deterioration
in Zmpste24-deficient mice is related with uncontrolled
autophagy activity (Mariño et al., 2008). In addition, the
Zmpste24-deficiency mice show a stress signaling
pathway associated with a strong hyperactivation of the
tumor suppressor p53 (Varela et al., 2005), reflecting the
key role of a deregulated p53 responses in premature
aging, which might be also linked to autophagy
impairment. Although, there is not relevant information
about the changes on NF-κB signaling or longevity
factor expression in these progeroid mice, it should be
noted that defective NF-κB transcriptional activity has
been previously shown in laminin A/C-deficient cells
(Lammerding et al., 2004). Therefore, further alterations
in cellular stress responses and longevity pathways
might be involved in the up-regulation of autophagy in
progeroid mice. 
Concluding remarks
Aging and autophagy are two processes that are
clearly dependent on increased ROS production, which
maintain a narrow, though inverse, relationship. It seems
that when people age, their autophagic capability
becomes reduced. This review shows that molecules,
such as sirtuins, p53 and NF-κB that are reported by
many articles to be key players in longevity, also have an
important role in autophagic regulation. The functions of
these molecules in both processes are conflicting and,
sometimes, confusing. Some reports show that, while
sirtuins and nuclear p53 induce autophagy, NF-κB
abolishes it (Fig. 2).
The relationship between aging and autophagy has
yet to be elucidated. Although some advances have been
made, results seem contradictory, and while certain
aging animal models show that autophagy decreases
with aging, progeria models present uncontrolled
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Fig.2. Influence of NF-κB, p53 and sirtuins on
autophagy activity. The positive effect of
autophagy on longevity can also be associated
with its well-known negative regulation of
neurodegenerative damages. Longevity factors,
such as sirtuins 1 (SIRT1), can positively affect
longevity by the direct activation of autophagy,
which directly impact against neuro-
degenerative levels. Likewise, there is a
negative regulation of autophagy by oxidative
stress-related transcriptional factors, such as
NF-κB signaling and p53 activity. In fact,
autophagy can be blocked by NF-κB-mediated
inflammation and levels of autophagic activity
can be modified according to the level of p53
acetylation.
autophagy increases.
Although this connection has huge research
potential, further experiments are required to gain a
better understanding for the complex interactions that
exits among longevity, neurodegeneration and
autophagy.
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